Skip to main content

Advertisement

Table 6 Postoperative complications in both groups

From: Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma

  Injection Group Control Group P
Anterior uveitis 7 (33.3 %) 10 (47.6 %) 0.42
Worsened corneal edema 2 (9.5 %) 2 (9.1 %) 0.96
Hyphema 9 (42.9 %) 9 (40.9 %) 0.90
Vitreous hemorrhage 2 (9.5 %) 5 (22.7 %) 0.23
Transient ocular hypertension 2 (9.5 %) 4 (18.2 %) 0.41
Malignant glaucoma 0 0  
Sustained low IOP 0 0  
Drainage tube obstruction/displacement/exposure 3 (14.3 %) 4 (18.2 %) 0.73
Lens opacity 1 (4.8 %) 0  
Choroidal hemorrhage/detachment 0 1 (4.5 %)  
Retinal detachment 0 0  
Conjunctival retraction/rupture 0 1 (4.5 %)  
Endophthalmitis 0 0  
Loss of light perception 0 0  
Total 12 (57.1 %) 14 (63.6 %) 0.66
  1. Note: The differences in postoperative complications were compared between the two groups using the chi-square or corrected chi-square test